YouTube Facebook LinkedIn Google+ Twitter Xingrss  

Foundation Medicine's IPO Prospects


August 1, 2013 | Foundation Medicine filed plans this week to raise $86.25 million in an IPO, and the Boston Globe posits it could be aiming too low. Another recent Third Rock Ventures biotech raised more than 20% more than it expected last week and Foundation Medicine's technology is strong. For background see Laying the Foundation for Next-Gen Cancer Diagnostics and Foundation Medicine Partners with Memorial Sloan-Kettering. Boston Globe
Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

For reprints and/or copyright permission, please contact  Jay Mulhern, (781) 972-1359, jmulhern@healthtech.com.